NCT05839509
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT05839509
- Registry
- ClinicalTrials.gov
- NCT number
- NCT05839509
- Asset
- GH001
- Sponsor, as registered
- GH Research Ireland Limited
- Phase
- PHASE2
- Indication
- Bipolar II Disorder
- Status
- TERMINATED
- Start date
- 2023-04-06
- Primary completion
- 2024-11-13
- Registered countries
- Germany, Netherlands, United Kingdom
- Sites
- 7
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-08-31
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country.
Company
Through GH001: GH Research
Cited in
No published issue cites this registry number.